Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

2.2K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.2K
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

4.6K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.6K
Bioremediation00:46

Bioremediation

22.6K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
22.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

5.4K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OT-55 reshapes tolerogenic BH3-mimetic-induced apoptosis toward immunogenic cell death in acute myeloid leukemia, potentiating PD-1/Tim-3 blockade.

Cell death & disease·2026
Same author

Oxidative stress drives liver failure during in vivo partial reprogramming.

Molecules and cells·2026
Same author

Human amygdala-like telencephalic organoids model stress circuitry in assembloid systems.

Cell stem cell·2026
Same author

Dysregulation of Hippo Signaling Pathway as a Convergent Mechanism Underlying Choroid Plexus Defects in Bipolar Disorder.

bioRxiv : the preprint server for biology·2026
Same author

Defective autophagy in GNE myopathy is rescued by inhibition of noncanonical Akt-mTORC1 activation across multiple isogenic models.

Experimental & molecular medicine·2026
Same author

Organ-Specific Dedifferentiation and Epigenetic Remodeling in In Vivo Reprogramming.

Aging cell·2025

Related Experiment Video

Updated: Feb 27, 2026

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

3.2K

Helping Induced hPSCs Clean Up Their Act.

Ho-Chang Jeong1, Hyuk-Jin Cha1

  • 1Department of Life Sciences, Sogang University, Seoul 04107, Republic of Korea.

Cell Chemical Biology
|June 24, 2017
PubMed
Summary
This summary is machine-generated.

Residual human pluripotent stem cells (hPSCs) pose a risk in cell therapy. A novel phospho-D-peptide, D-3, effectively eliminates these cells by targeting their high alkaline phosphatase activity.

More Related Videos

Enrichment and Purging of Human Embryonic Stem Cells by Detection of Cell Surface Antigens Using the Monoclonal Antibodies TG30 and GCTM-2
12:43

Enrichment and Purging of Human Embryonic Stem Cells by Detection of Cell Surface Antigens Using the Monoclonal Antibodies TG30 and GCTM-2

Published on: December 6, 2013

8.2K
Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency
09:07

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency

Published on: June 10, 2018

10.7K

Related Experiment Videos

Last Updated: Feb 27, 2026

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

3.2K
Enrichment and Purging of Human Embryonic Stem Cells by Detection of Cell Surface Antigens Using the Monoclonal Antibodies TG30 and GCTM-2
12:43

Enrichment and Purging of Human Embryonic Stem Cells by Detection of Cell Surface Antigens Using the Monoclonal Antibodies TG30 and GCTM-2

Published on: December 6, 2013

8.2K
Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency
09:07

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency

Published on: June 10, 2018

10.7K

Area of Science:

  • Stem Cell Biology
  • Regenerative Medicine
  • Chemical Biology

Background:

  • Human pluripotent stem cells (hPSCs) hold great promise for regenerative medicine.
  • Ensuring the safety of hPSC-based therapies requires eliminating residual undifferentiated cells.
  • Residual hPSCs possess tumorigenic potential, posing a significant risk.

Purpose of the Study:

  • To identify a method for selectively eliminating residual hPSCs in cell therapy.
  • To investigate the efficacy of phospho-D-peptide D-3 in targeting hPSCs.

Main Methods:

  • Treatment of hPSCs and differentiated cells with phospho-D-peptide D-3.
  • Analysis of cell viability and death.
  • Assay of alkaline phosphatase activity in hPSCs.

Main Results:

  • Phospho-D-peptide D-3 efficiently induced death in residual hPSCs.
  • Differentiated progenies were not affected by D-3 treatment.
  • High alkaline phosphatase activity in hPSCs was identified as the mechanism of D-3 action.

Conclusions:

  • Phospho-D-peptide D-3 is a potent agent for selectively eliminating residual hPSCs.
  • This finding offers a promising strategy for enhancing the safety of hPSC-based therapies.